Webinar: Nirmatrelvir/ritonavir for COVID-19: Test, Treat and Therapeutic Updates
![20220928 – Nirmatrelvir ritonavir for COVID-19 Title Slide](https://www.seaetc.com/wp-content/uploads/2022/09/20220928-Nirmatrelvir-ritonavir-for-COVID-19-Title-Slide.jpg)
Facilitated by Marylee Worley Tailor, PharmD, BCIDP
Faculty, South Florida- Southeast AIDS Education &Training Center
Assistant Professor, Pharmacy Practice
Nova Southeastern University
September 28, 2022
Objectives
- Describe the current evidence and therapeutic considerations for the use of nirmatrelvir/ritonavir to treat COVID-19
- Discuss important drug-drug interactions when prescribing nirmatrelvir/ritonavir for COVID-19
- Discuss new laws and regulations related to test and treat and pharmacists role in expanding nirmatrelvir/ritonavir uptake
Presentation
Slides
![20220928 – Nirmatrelvir ritonavir for COVID-19 Title Slide](https://www.seaetc.com/wp-content/uploads/2022/09/20220928-Nirmatrelvir-ritonavir-for-COVID-19-Title-Slide.jpg)
Facilitated by Marylee Worley Tailor, PharmD, BCIDP
Faculty, South Florida- Southeast AIDS Education &Training Center
Assistant Professor, Pharmacy Practice
Nova Southeastern University
September 28, 2022
Objectives
- Describe the current evidence and therapeutic considerations for the use of nirmatrelvir/ritonavir to treat COVID-19
- Discuss important drug-drug interactions when prescribing nirmatrelvir/ritonavir for COVID-19
- Discuss new laws and regulations related to test and treat and pharmacists role in expanding nirmatrelvir/ritonavir uptake